Micral-Test Microalbuminuria Roche (30)
Roche Micral-Test strips allow detection of microalbuminuria in just one minute. With a sensitivity of 20 mg/L, these urine tests facilitate early detection of kidney damage in diabetic and hypertensive patients. Simple visual reading by colorimetric comparison. Box of 30 reactive strips for urinary albumin analysis.
Référence |
11544039171 |
Associated categories: Diagnostic testing equipment > Urine tests > Micral-Test Microalbuminuria Roche (30)
Features:
- Urine test strips for microalbuminuria detection
- Roche brand, Micral-Test reference
- Box of 30 ready-to-use test strips
- Results in 1 minute by visual reading
- Detection threshold: 20 mg/L albumin
- Result scale: negative, 20, 50, >100 mg/L
- Comparison with provided color scale
- Color stability for 5 minutes after immersion
- Indication: early detection of nephropathies
- Target populations: diabetic patients, hypertensive patients
- Identifies high cardiovascular risk
- Storage temperature: 2 to 30 °C
- No reading device required
Often bought together
Early detection that makes all the difference in monitoring my at-risk patients.
Frequently asked questions
What is the difference between microalbuminuria and standard proteinuria?
Microalbuminuria corresponds to urinary albumin excretion between 20 and 200 mg/L, an early stage of kidney damage. Standard proteinuria refers to higher concentrations, detectable by standard test strips. The Micral-Test is specifically designed to detect these small amounts of albumin before advanced kidney damage appears.
How to interpret Micral-Test Roche results?
After 1 minute of immersion, compare the color of the reactive zone to the provided scale. A negative result indicates less than 20 mg/L of albumin. Values of 20, 50 or >100 mg/L indicate microalbuminuria requiring medical monitoring. The reading must be performed within 5 minutes after the test.
How often should microalbuminuria testing be performed in a diabetic patient?
Medical recommendations generally suggest annual microalbuminuria screening in type 2 diabetic patients from diagnosis, and in type 1 diabetics after 5 years of disease. If results are positive, closer monitoring may be indicated by the physician.